Vantage Consulting Group Inc

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    virginia beach, VA
  • CIK
    0001843547
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

5

$10.49M
BW, CBUS, ADC THERAPEUTICS SA, PBPB
13F-HR
Feb 12, 2025
000184354725000004

4

$11.42M
BW, CBUS, ADC THERAPEUTICS SA, FGEN
13F-HR
Nov 14, 2024
000117266124004815

191

$134.56M
SSPY, CBUS, SMDY, BW
13F-HR
Aug 14, 2024
000117266124003456

212

$157.27M
SSPY, CBUS, SMDY, ADC THERAPEUTICS SA
13F-HR
May 15, 2024
000117266124002438

208

$148.82M
SSPY, CBUS, SMDY, BW
13F-HR
Feb 14, 2024
000117266124001168

200

$149.18M
SSPY, CBUS, BW, SMDY
13F-HR
Nov 14, 2023
000117266123003968

216

$173.85M
SSPY, ROYALTY PHARMA PLC, BW, CBUS
13F-HR
Aug 11, 2023
000117266123002954

231

$176.12M
SSPY, ROYALTY PHARMA PLC, SMDY, FGEN
13F-HR
May 10, 2023
000117266123001956

212

$169.39M
SSPY, ROYALTY PHARMA PLC, FGEN, SMDY
13F-HR
Feb 13, 2023
000117266123000752

213

$171.17M
SSPY, ROYALTY PHARMA PLC, FGEN, ADC THERAPEUTICS SA
13F-HR
Nov 14, 2022
000160658722002318

213

$178.34M
SSPY, ROYALTY PHARMA PLC, ADC THERAPEUTICS SA, FGEN
13F-HR
Aug 9, 2022
000160658722001672

215

$256.28M
ROYALTY PHARMA PLC, SSPY, ADC THERAPEUTICS SA, FGEN
13F-HR
May 16, 2022
000160658722001175

231

$371.95M
ROYALTY PHARMA PLC, SSPY, ADC THERAPEUTICS SA, ITCI
13F-HR
Feb 14, 2022
000160658722000518

206

$466.97M
ROYALTY PHARMA PLC, SSPY, ADC THERAPEUTICS SA, ITCI
13F-HR
Nov 10, 2021
000160658721001573

211

$574.83M
ROYALTY PHARMA PLC, SSPY, ADC THERAPEUTICS SA, FGEN
13F-HR
Aug 11, 2021
000160658721001110

99

$498.16M
ROYALTY PHARMA PLC, ADC THERAPEUTICS SA, FGEN, SSPY
13F-HR
May 14, 2021
000160658721000721

1,884

$1.23B
ROYALTY PHARMA PLC, ADC THERAPEUTICS SA, FGEN, ITCI
13F-HR
Feb 12, 2021
000160658721000323
Vantage Consulting Group Inc 13F Filings